Last time I posted was about P300 latency. A very valid question to which I got reassuring answers. Ward made no mention of P300 latencies that I'm aware of. He commented little on the science behind 2-73, except to say he was concerned about the small number of patients (n=12) reported on back on 7/22.
I'm a new to the game of investing in individual stocks and have questions, so don't judge me as if I've been doing this for years.